AI Structured Summary
Not yet generated for this judgment
No AI summary yet
Generate an eight-section analysis of this judgment — facts, issues, reasoning, ratio and a plain-language gist.
Judgment
92 paragraphs · 2,060 wordsKailasam, C.J.—This appeal is preferred by Mount Mettur Pharmaceuticals (P) Ltd., against the judgment of Ganesan J. in A. A. O. 369 of
1966, dismissing the appellant''s application to register his trade mark.
The appellant made an application for registration of a trade mark consisting of the word ''Asthmix'' in Part A of the Register in Class 5 in
respect of a designation of goods, which, after amendment, read ''Pharmaceutical preparation for the treatment of Asthma''. A notice of opposition
was lodged by the first respondent under S. 21 of the Trade and Merchandise Marks Act, 1958. The main grounds of opposition were that the
opponents are the proprietors in India of the trade mark ''Asmac'' registered under Cl. 5 in respect of pharmaceutical preparation for the treatment
of asthma, that by long and extensive user the said trade mark had become exclusively associated by the trade and the public in India with them
and had acquired a great reputation, that the appellant''s trade mark is deceptively similar to theirs, that the appellant''s mark did no qualify for
registration u/s 9 of the Act and that in view of the deceptive similarity, the appellant''s application should be rejected.
The Assistant Registrar of Trade Marks found that there was a real tangible danger of confusion in the minds of the public. He also found that
this is not a case where registration under S. 12(3) of the Act should be given. In the result, he dismissed the application with costs of the
opponents.
On appeal by the appellant, Ganesan J. while finding that the marks are admittedly not identical, held that there was no visual similarity between
the two competing marks and the phonetical test alone has to be applied to this case. In applying the phonetical test the learned Judge found that
the persons who may be deputed for buying these medicines are mostly Indians and that their pronunciations of the English words are not likely to
be perfect and proper and that these words are likely to be pronounced in various manner differing from State to State and from locality to locality
depending upon the language used by the customers and their state of literacy. According to the learned Judge, the chances of confusion will be
very little, but customers are not likely to hail only from the group of literate persons well versed in English language. The learned Judge upheld the
conclusion arrived at by the Assistant Registrar that the confusion among the public as regards the trade origin of these competing goods cannot be
ruled out. He also held that the appellant is not entitled to registration under Sec. 12(3) of the Act. Agreeing with the Registrar, the learned Judge
dismissed the appeal.
The appellant asked for registration of the mark consisting of the word ''Asthmix'' in Part A of the Register in class 5 in respect of
Pharmaceutical preparation for the treatment of asthma. The appellant''s medicine is packed in folders and bottles covered by a carton. The
respondent''s mark is registered with the word ''Asmac'' in class 5 in respect of Pharmaceutical preparation for the treatment of asthma. The
packing is in a small carton consisting of 20 tablets whereas that of the appellant is in folders consisting of ten tablets and in bottles for the liquid
form. There is absolutely no similarity and no purchaser, whether intelligent or unwary could mistake one medicine for the other. This is the finding
of the Assistant Registrar, though not in such specific words. After discussing the question of similarity, the Assistant Registrar observed-
At first blush, I thought that such an objection would not be available to the opponents.
The learned Judge also found that the marks are admittedly not identical and there is no visual similarity between the two competing marks. We
have no hesitation in accepting these findings and holding that there is no similarity whatsoever between the two products. It is also the admitted
case of the parties.
It was urged that the words are deceptively similar, Section 11 of the Act states that a mark, the use of which would be likely to deceive or
cause confusion, shall not be registered as a trade mark, Section 12(1) provides that save as provided in sub-section (3), no trade mark shall be
registered in respect of any goods or description of gods which is identical with or deceptively similar to a trade mark which is already registered in
the name of a different proprietor in respect of the same goods or description of goods. The words ''deceptively similar'' are defined in Section
2(1)(d) as ''a mark shall be deemed to be deceptively similar to another mark if it so nearly resembles that other mark as to be likely to deceive or
cause confusion''. The effect of Sections 11 and 12 is that the mark shall not be registered, if the use o it would be likely to deceive or cause
confusion and the goods are deceptively similar. The finding which we have already recorded would rule out any deceptive similarity or use of
which would likely deceive or cause confusion. In spite of this finding, which in fact is not disputed, we would proceed to consider whether the
order refusing registration by the Assistant Registrar and the learned Judge should be set aside.
The main ground on which the Assistant Registrar, whose opinion was accepted by the learned Judge, refused to register the trade mark is that
there is phonetical similarity. The drugs are ''Asthmix'' and ''Asmac''. At the first blush or on the first impression there could be no difficulty in
coming to the conclusion that there is no similarity. But we have been taken through a number of decisions by both sides, each supporting its own
stand. It may be frankly stated that it is difficult to deduce any principle of law from these decisions. The decisions have been rendered on the facts
of the case and sometimes appear to be irreconcilable. In the circumstances, we would follow the principles laid down in Halsbury''s Laws of
England, Vol. 38, Simonds Edn. and by Lord Parker in Pianotist Co. Ltd., application 1906-23 RPC 774. In Halsbury''s Laws of England, Vol.
38 at page 586, it is stated-
Thus, in the case of applications for registration of trade marks and in oppositions thereto, the onus is on the applicant to satisfy the Registrar that
the trade mark applied for is not likely to deceive or8 cause confusion.
As regards resemblance, it is stated that it is a question of fact. The author observes-
Whether or not any degree of resemblance likely to deceive or cause confusion exists, is a question of fact for the tribunal or court to decide upon
the evidence in each case and is not a matter for witnesses. What degree of resemblance is likely to deceive or cause confusion in any instance is
incapable of definition a priori and the observations of Judges upon other and quite different facts are usually of little help.
We resist from getting confused y referring to various decisions which deal with the particular trade mark under contest and would confine
ourselves mainly to the facts of the case. In the oft quoted decision in Pianotist Co. Ltd.''s application, 1906-23 RPC 774, Lord Parker has laid
down the tests as follows-
You must take the two words, you must judge of them, both by their look and by their sound. You must consider the goods to which they are to
be applied. You must consider the nature and kind of customers who would be likely to buy those goods. In fact, you must consider all the
surrounding circumstances and you must further consider what is likely to happen if each of those trade marks is used in a normal way as a trade
mark for the goods of the respective owners of the marks. If, considering all those circumstances, you come to the conclusion that there will be a
confusion that is to say, not necessarily that one man will be injured and the other will gain illicit benefit, but that there will be a confusion in the
mind of the public which will lead to confusion in the goods then you may refuse the registration, or rather you must refuse the registration in that
case.
The primary tests are that the words should be judged by their look and by their sound. There is no similarity in the goods by their look in the
present case. ''Asthmix'' and ''Asmac'' in our view are not similar in sound and are not likely to confuse any person. The reason given by the
learned Judge is that the person who may buy the medicine such as nurses, compounders and other laymen in charge of the hospital and similar
institutions are mostly Indians and that their pronunciation of the English words are not likely to be perfect and proper. It may be stated here that
this medicine can be dispensed only on the prescription of the doctors. According to the learned Judge, the customers are not likely to hail only
from the group of literate persons well versed in English language. The learned Judge expressed the view that orders for the preparation of the drug
''asmac'' are placed over the telephone and are indistinctly heard over and that written prescriptions are misspelt or badly written. He felt that
nurses, compounders and lay people in charge of the hospital and similar institutions may place orders orally or across the counter or over he
phone, which may lead to some confusion. With respect, we do not accept these as proper tests. These medicines are schedule H drugs and can
only be dispensed on the prescription of the medical practitioner.
Before the Assistant Registrar and the learned Judge, the appellant stated that he would be satisfied if the registration of the word ''asthmix'' is
confined to the drug which contained any of the drugs mentioned in schedule H. The question of an innocent and unwary purchaser walking to the
shop and purchasing the medicine without a prescription does not arise. The medicine has to be dispensed on the counter on the prescription of the
doctor. One can expect a compounder to dispense the medicine properly unless he is grossly negligent, for which contingency the trade mark law
cannot give any protection. When a person authorised under the Act, namely, doctor, nurse or a compounder deputed by the hospital or similar
institutions, goes to a pharmacy for buying the medicines, it is presumed that he is sufficiently informed as not to mistake one medicine for the other,
when there is no similarity between the two drugs. It is farfetched to say that these persons are defective in the pronunciation of the English words
making it possible that they would mix up between ''Asthmix'' and ''asmac''. We are aware of the fact that in the case of pharmaceutical drugs, the
court should be careful not to permit any room for confusion. The possibility of confusion is for a normal buyer or even an unwary purchaser and
not for fools and idiots.
On a consideration of the entire facts of the case, we are satisfied that there is no deceptive similarity between the two marks. We are also satisfied
that the Assistant Registrar was in error in refusing to register. It was contended that the decision of the Assistant Registrar should not be lightly
interfered with by this court. If two views are possible and the Assistant Registrar has taken one view, the court would be reluctant to interfere with
his discretion. But in a case where the court is convinced that the Assistant Registrar is in error in refusing to register the trade mark on the ground
that there is deceptive similarity between the two marks, it is the duty of the court to interfere. It is not necessary to go into the question whether
the mark should be registered u/s 12(3) of the Act, as we are satisfied that it should be registered u/s 12(1). In the result, the appeal is allowed and
the Assistant Registrar is directed to register the trade mark under Part A of the Register in Class 5 as prayed for. There will be no order as to
costs.
Appeal allowed.
